Annovis Bio, Inc. (ANVS)
NYSE: ANVS · Real-Time Price · USD
1.490
-0.010 (-0.67%)
At close: Apr 1, 2025, 4:00 PM
1.532
+0.042 (2.82%)
After-hours: Apr 1, 2025, 7:56 PM EDT

Annovis Bio Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2017
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019 - 2017
Net Income
-24.59-56.2-25.33-14.49-5.46
Upgrade
Other Amortization
----0
Upgrade
Stock-Based Compensation
3.844.639.154.71.86
Upgrade
Other Operating Activities
-1.8211.84--0.03
Upgrade
Change in Accounts Payable
1.01-2.673.270.35-0.7
Upgrade
Change in Other Net Operating Assets
-0.332.44-4.410.310.29
Upgrade
Operating Cash Flow
-21.89-39.97-17.31-9.13-3.97
Upgrade
Issuance of Common Stock
26.6917.34046.7412.04
Upgrade
Financing Cash Flow
26.6917.34046.7412.04
Upgrade
Net Cash Flow
4.8-22.62-17.3137.618.07
Upgrade
Levered Free Cash Flow
-12.17-23.75-7.93-3.73-3.02
Upgrade
Unlevered Free Cash Flow
-12.17-23.75-7.93-3.73-3.02
Upgrade
Change in Net Working Capital
-0.680.231.14-0.660.73
Upgrade
Updated Mar 21, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q